Mitochondrial dysfunction in Huntington's disease

C Carmo, L Naia, C Lopes, AC Rego - Polyglutamine disorders, 2018 - Springer
Mitochondrial dysfunction has been described as an early pathological mechanism
delineating the selective neurodegeneration that occurs in Huntington's disease (HD), a …

Oxidative damage in Huntington's disease pathogenesis

SE Browne, MF Beal - Antioxidants & redox signaling, 2006 - liebertpub.com
Huntington's disease (HD) is a devastating neurodegenerative disorder characterized by the
progressive development of involuntary choreiform movements, cognitive impairment …

Inhibition of mitochondrial fragmentation diminishes Huntington's disease–associated neurodegeneration

X Guo, MH Disatnik, M Monbureau… - The Journal of …, 2013 - Am Soc Clin Investig
Huntington's disease (HD) is the result of expression of a mutated Huntingtin protein (mtHtt),
and is associated with a variety of cellular dysfunctions including excessive mitochondrial …

FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease

K Jin, M LaFevre-Bernt, Y Sun… - Proceedings of the …, 2005 - National Acad Sciences
There is no satisfactory treatment for Huntington's disease (HD), a hereditary
neurodegenerative disorder that produces chorea, dementia, and death. One potential …

Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model

T Nguyen, A Hamby, SM Massa - Proceedings of the …, 2005 - National Acad Sciences
In investigating the role of metal ions in the pathogenesis of Huntington's disease, we
examined the effects of clioquinol, a metal-binding compound currently in clinical trials for …

Glucose metabolic dysfunction in neurodegenerative diseases—new mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic …

R Han, J Liang, B Zhou - International Journal of Molecular Sciences, 2021 - mdpi.com
Glucose is the main circulating energy substrate for the adult brain. Owing to the high energy
demand of nerve cells, glucose is actively oxidized to produce ATP and has a synergistic …

Retracted: Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease

A Valencia, E Sapp, JS Kimm, H McClory, PB Reeves… - 2017 - academic.oup.com
The corresponding author requests retraction of the above referenced article due to
inappropriate manipulation and fabrication of data by the first author Dr. Antonio Valencia …

Altered placental tryptophan metabolic pathway in human fetal growth restriction

P Murthi, EM Wallace, DW Walker - Placenta, 2017 - Elsevier
Introduction Tryptophan is a substrate for kynurenine pathway metabolism in the placenta.
We investigated if kynurenine metabolites change over gestation, if they are different …

Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats

M Tariq, HA Khan, I Elfaki, S Al Deeb… - Brain research bulletin, 2005 - Elsevier
Nicotinic acetylcholine receptors (nAChRs) are regarded as potential therapeutic targets to
control various neurodegenerative diseases. Owing to the relevance of cholinergic …

YAC128 Huntington׳ s disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease

M Ghilan, CA Bostrom, BN Hryciw, JM Simpson… - Brain research, 2014 - Elsevier
Huntington׳ s disease (HD) is a progressive and fatal neurodegenerative disorder caused by
a polyglutamine expansion in the gene encoding the protein huntingtin. The disease …